ATE138571T1 - Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus. - Google Patents

Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus.

Info

Publication number
ATE138571T1
ATE138571T1 AT91309685T AT91309685T ATE138571T1 AT E138571 T1 ATE138571 T1 AT E138571T1 AT 91309685 T AT91309685 T AT 91309685T AT 91309685 T AT91309685 T AT 91309685T AT E138571 T1 ATE138571 T1 AT E138571T1
Authority
AT
Austria
Prior art keywords
dioxabicyclo
drug
production
cholesterol metabolism
inhibiting cholesterol
Prior art date
Application number
AT91309685T
Other languages
English (en)
Inventor
Kengo Akimoto
Sumio Asami
Michihiro Sugano
Nobuaki Hirose
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17644733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE138571(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE138571T1 publication Critical patent/ATE138571T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT91309685T 1990-10-22 1991-10-21 Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus. ATE138571T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28183990A JP3183664B2 (ja) 1990-10-22 1990-10-22 コレステロール及び胆汁酸の代謝阻害剤

Publications (1)

Publication Number Publication Date
ATE138571T1 true ATE138571T1 (de) 1996-06-15

Family

ID=17644733

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91309685T ATE138571T1 (de) 1990-10-22 1991-10-21 Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus.

Country Status (9)

Country Link
US (1) US5270335A (de)
EP (1) EP0488513B1 (de)
JP (1) JP3183664B2 (de)
AT (1) ATE138571T1 (de)
CA (1) CA2053820C (de)
DE (1) DE69119875T2 (de)
DK (1) DK0488513T3 (de)
ES (1) ES2087252T3 (de)
GR (1) GR3020682T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
JPH06227977A (ja) * 1993-02-01 1994-08-16 Suntory Ltd 活性酸素消去剤
JPH10500937A (ja) * 1994-02-25 1998-01-27 ニュー イングランド ディーコネス ホスピタル コーポレイション セサミン系リグナンの抗炎症及び感染防護効果
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤
DK0782827T3 (da) * 1995-07-04 2004-02-09 Suntory Ltd Anvendelse af et afbalanceringsmiddel til omega-6- og omega-3-umættede fedtsyrer
JPH11246427A (ja) * 1998-03-04 1999-09-14 Kadoya Sesami Mills Inc 糖・脂質代謝活性化剤
KR100352269B1 (ko) * 1999-10-08 2002-09-12 한국생명공학연구원 저밀도 지질 단백질에 대해 항산화 활성을 갖는 리그난계 화합물
JP4388248B2 (ja) * 2001-10-29 2009-12-24 株式会社日立製作所 最適ポートフォリオ決定方法および装置
US7081260B2 (en) * 2002-10-29 2006-07-25 Council Of Scientific And Industrial Research α-Glucosidase inhibitors from a natural source
CA2603347C (en) * 2005-03-31 2014-06-17 Suntory Limited Oil-in-water emulsions of lignans that exhibit improved absorption rate
WO2007037385A1 (ja) 2005-09-30 2007-04-05 Suntory Limited エピセサミン高含有組成物の製造方法及び装置
US9408803B2 (en) 2006-03-31 2016-08-09 Suntory Holdings Limited Compositions containing lignan-class compounds
AU2007305614B2 (en) 2006-10-04 2012-08-23 Suntory Holdings Limited O/W/O emulsion containing lignan compounds and composition containing the same
JP5051878B2 (ja) * 2007-03-02 2012-10-17 竹本油脂株式会社 高濃度セサミノール含有物の製造方法
SG10201510301UA (en) 2007-09-19 2016-01-28 Suntory Holdings Ltd Compositions incorporating sesamin-class compounds and vitamin b1 class compounds
JP7366991B2 (ja) * 2019-02-28 2023-10-23 株式会社えがお 体重増加抑制・低減用組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2235205T3 (es) * 1989-07-21 2005-07-01 Suntory Limited Capsula que contiene compuestos de dioxabiciclo (3.3.0)octano.

Also Published As

Publication number Publication date
ES2087252T3 (es) 1996-07-16
DE69119875D1 (de) 1996-07-04
EP0488513A3 (de) 1992-06-17
EP0488513A2 (de) 1992-06-03
DE69119875T2 (de) 1996-10-02
US5270335A (en) 1993-12-14
CA2053820C (en) 1997-02-04
EP0488513B1 (de) 1996-05-29
DK0488513T3 (da) 1996-06-17
CA2053820A1 (en) 1992-04-23
JPH04159221A (ja) 1992-06-02
GR3020682T3 (en) 1996-10-31
JP3183664B2 (ja) 2001-07-09

Similar Documents

Publication Publication Date Title
ATE138571T1 (de) Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus.
AU6128590A (en) Novel compounds
FI92399B (fi) Menetelmä lääkeaineena käyttökelpoisen tiatsolidinonin johdannaisen valmistamiseksi
DK444685D0 (da) Tiazolidindionderivater, farmaceutiske praeparater indeholdende dem ogfremgangsmaader til fremstilling deraf
AU6129890A (en) Novel compounds
DE69230958D1 (de) Arzneizusammensetzung auf Basis von Dioxabicyclo[3.3.0]octanderivaten
IL102093A0 (en) 1-methylcarbapenem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
ZA898678B (en) Compositions and compounds
ATE60763T1 (de) Pyrrolidinylamidesterderivate mit antiprolylendopeptidaseaktivitaet, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen.
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
LV10235A (lv) Jauni esteri to iegusanas panemiens farmaceitiska kompozicija arstesanas metode
KR860008973A (ko) 2-피롤리돈 유도체
HUT39448A (en) Process for producing 1,6-naphtiridine derivatives and pharmaceutical compositions containing them
BG101501A (en) Nitro-benzamides useful as anti-arrhytmic agents
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
DE69533298D1 (de) Dioxabicyclo 3.3.0 octan-Derivate, z.B. Sesamin etc., zur Vorbeugung und Erleichterung von Allergiesymptomen
DE68924991D1 (de) 2-Pyranon-Derivat und Verfahren zu dessen Herstellung.
ATE168371T1 (de) 5-amino-5,6,7,8-tetrahydrochinoline und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
MY107827A (en) Isoquinolline compounds, compositions and use
ATE125256T1 (de) Zwischenprodukte der mureidomycin-gruppe, ihre herstellung und verwendung.
ATE36154T1 (de) 4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
EP0441116A3 (en) Optically active chroman derivatives and intermediates thereof, and process for manufacturing same
DE69214180D1 (de) Verwendung von Bis-(p-Hydroxyphenylthio)methanderivaten zur Hemmung der fortschreitenden Entwicklung von insulinabhängingem Diabetes mellitus
HUT47929A (en) Process for producing 4-piperidine-carboxamide derivatives and pharmaceuticals comprising same
ATE186907T1 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee